Back to Nephrology
Nephrologyv2020Evidence-Based

Acute Interstitial Nephritis (AIN) Risk Calculator

Identifies the likelihood of acute interstitial nephritis in at-risk patients undergoing kidney biopsy evaluation. Uses commonly available clinical and laboratory parameters to predict AIN probability.

Clinical Input Parameters

mg/dL
Range: 0.1 — 20 mg/dL
mg/dL
Range: 1 — 300 mg/dL
Range: 1 — 1.05
proportion
Range: 0.01 — 1 proportion
Clinical Assessment
Awaiting Parameters
ain probability
—probability
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Acute Interstitial Nephritis (AIN) Risk Calculator is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within nephrology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Logistic regression model using creatinine, BUN, urine specific gravity, urine protein, and local AIN prevalence to calculate probability of acute interstitial nephritis

Clinical Pearls & Practice Notes

  • Should only be used for patients in whom a kidney biopsy is being considered
  • Developed from multicenter data including Yale, Indiana University, and Johns Hopkins
  • Model showed AUC of 0.73-0.74 in external validation with high negative predictive value (>90%)
  • Helps distinguish AIN from other causes of acute kidney injury
  • Important for guiding decisions about medication discontinuation and corticosteroid therapy

Evidence & Literature Citations

  1. Moledina DG, Luciano RL, Kukova L, et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol. 2018;13(11):1633-1640.
  2. Moledina DG, Wilson FP, Kukova L, et al. Prevalence and outcomes of kidney biopsy in hospitalized patients with acute kidney injury. J Am Soc Nephrol. 2017;28(4):1342-1349.
  3. Perazella MA, Moledina DG. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 2017;12(12):2046-2049.

Score Interpretation Ranges

Low Risk0 – 0.2 pts

Low probability of AIN

Intermediate Risk0.2 – 0.5 pts

Intermediate probability of AIN

High Risk0.5 – 1 pts

High probability of AIN

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.